Hematopoietic stem cell transplantation does not increase the risk of infection‐related complications for pediatric patients with Hodgkin and non‐Hodgkin lymphomas: A multicenter nationwide study-Reference-Cited by-同舟云学术

Hematopoietic stem cell transplantation does not increase the risk of infection‐related complications for pediatric patients with Hodgkin and non‐Hodgkin lymphomas: A multicenter nationwide study

Published:2020-04-23 Issue:4 Volume:22 Page:
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transpl Infect Dis

Author:

Zając‐Spychała O.¹^ORCID,Wachowiak J.¹,Czyżewski K.²^ORCID,Dziedzic M.²,Wysocki M.²,Zalas‐Więcek P.³,Szmydki‐Baran A.⁴,Hutnik Ł.⁴,Matysiak M.⁴,Małas Z.⁵,Badowska W.⁵,Gryniewicz–Kwiatkowska O.⁶,Gietka A.⁶,Dembowska‐Bagińska B.⁶,Semczuk K.⁷,Dzierżanowska‐Fangrat K.⁷,Bartnik M.⁸,Ociepa T.⁸,Urasiński T.⁸,Frączkiewicz J.⁹,Salamonowicz M.⁹,Kałwak K.⁹,Gorczyńska E.⁹,Chybicka A.⁹,Irga‐Jaworska N.¹⁰,Bień E.¹⁰,Drożyńska E.¹⁰,Chełmecka‐Wiktorczyk L.¹¹,Balwierz W.¹¹,Zak I.¹²,Pierlejewski F.¹³,Młynarski W.¹³,Urbanek‐Dądela A.¹⁴,Karolczyk G.¹⁴,Stolpa W.¹⁵,Sobol‐Milejska G.¹⁵,Płonowski M.¹⁶,Krawczuk‐Rybak M.¹⁶,Musiał J.¹⁷,Chaber R.¹⁷,Gamrot‐Pyka Z.¹⁸,Woszczyk M.¹⁸,Tomaszewska R.¹⁹,Szczepański T.¹⁹,Kowalczyk J.²⁰,Styczyński J.²^ORCID

Affiliation:

1. Department of Pediatric Oncology, Hematology and Transplantology University of Medical Sciences Poznan Poland

2. Department of Pediatric Hematology and Oncology Collegium Medicum Nicolaus Copernicus University Torun Bydgoszcz Poland

3. Department of Microbiology Collegium Medicum Nicolaus Copernicus University Torun Bydgoszcz Poland

4. Department of Pediatric Hematology and Oncology Medical University Warszawa Poland

5. Division of Pediatric Hematology and Oncology Children Hospital Olsztyn Poland

6. Department of Oncology Children’s Memorial Health Institute Warszawa Poland

7. Department of Microbiology Children’s Memorial Health Institute Warszawa Poland

8. Department of Pediatrics Hemato‐Oncology and Gastroenterology Pomeranian Medical University Szczecin Poland

9. Department of Pediatric Stem Cell Transplantation, Hematology and Oncology Medical University Wroclaw Poland

10. Department of Pediatrics, Hematology and Oncology Medical University Gdansk Poland

11. Department of Pediatric Oncology and Hematology Collegium Medicum University Children’s Hospital Jagiellonian University Krakow Poland

12. Department of Microbiology Collegium Medicum University Children’s Hospital Jagiellonian University Krakow Poland

13. Department of Pediatric Oncology, Hematology and Diabetology Medical University Lodz Poland

14. Division of Pediatric Hematology and Oncology Children Hospital Kielce Poland

15. Division of Pediatric Oncology, Hematology and Chemotherapy Department of Pediatric Silesian Medical University Katowice Poland

16. Department of Pediatric Oncology and Hematology Medical University Bialystok Poland

17. Department of Pediatric Oncohematology Children Hospital Rzeszow Poland

18. Division of Pediatric Hematology and Oncology Chorzow Pediatric and Oncology Center Chorzow Poland

19. Department of Pediatric Hematology and Oncology Silesian Medical University Zabrze Poland

20. Department of Pediatric Hematology, Oncology and Stem Cell Transplantation Medical University Lublin Poland

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tid.13292

Reference21 articles.

1. Risk of chemotherapy-induced neutropenic complications when treating patients with non-Hodgkin lymphoma

2. A Review of Autologous Stem Cell Transplantation in Lymphoma

3. Is antimicrobial prophylaxis necessary for lymphoma patients? A single centre, real-life experience

4. Non‐Hodgkin lymphoma in children and adolescents;Reiter A;Klin Padiatr,2013

5. Results of the randomized Intergroup trial Inter‐B‐NHL Ritux 2010 for children and adolescents with high‐risk B‐cell non‐Hodgkin lymphoma (B‐NHL) and mature acute leukemia (B‐AL): evaluation of rituximab (R) efficacy in addition to standard LMB chemotherapy (CT) regimen;Minard‐Colin V;J Clin Oncol